MX372739B - Metodos y composiciones para inhibir cnksr1. - Google Patents
Metodos y composiciones para inhibir cnksr1.Info
- Publication number
- MX372739B MX372739B MX2015007608A MX2015007608A MX372739B MX 372739 B MX372739 B MX 372739B MX 2015007608 A MX2015007608 A MX 2015007608A MX 2015007608 A MX2015007608 A MX 2015007608A MX 372739 B MX372739 B MX 372739B
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- compositions
- cnksr1
- inhibiting
- inhibiting cnksr1
- Prior art date
Links
- 102100040450 Connector enhancer of kinase suppressor of ras 1 Human genes 0.000 title abstract 3
- 101000749825 Homo sapiens Connector enhancer of kinase suppressor of ras 1 Proteins 0.000 title abstract 3
- 230000002401 inhibitory effect Effects 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261737658P | 2012-12-14 | 2012-12-14 | |
| PCT/US2013/075505 WO2014093988A2 (en) | 2012-12-14 | 2013-12-16 | Methods and compositions for inhibiting cnksr1 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2015007608A MX2015007608A (es) | 2016-04-13 |
| MX372739B true MX372739B (es) | 2020-05-06 |
Family
ID=50935099
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015007608A MX372739B (es) | 2012-12-14 | 2013-12-16 | Metodos y composiciones para inhibir cnksr1. |
| MX2019015648A MX393754B (es) | 2012-12-14 | 2013-12-16 | Metodos y composiciones para inhibir cnksr1 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019015648A MX393754B (es) | 2012-12-14 | 2013-12-16 | Metodos y composiciones para inhibir cnksr1 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9340532B2 (enExample) |
| EP (1) | EP2931280B1 (enExample) |
| JP (1) | JP6357292B2 (enExample) |
| AU (1) | AU2013358876B2 (enExample) |
| CA (1) | CA2895162C (enExample) |
| MX (2) | MX372739B (enExample) |
| WO (1) | WO2014093988A2 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2895162C (en) | 2012-12-14 | 2021-03-09 | D. Lynn Kirkpatrick | Methods and compositions for inhibiting cnksr1 |
| WO2016172191A1 (en) * | 2015-04-20 | 2016-10-27 | Phusis Therapeutics, Inc. | Compounds, compositions and methods for inhibiting cnksr1 |
| US20190367457A1 (en) | 2016-12-30 | 2019-12-05 | Mitobridge, Inc. | Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (acmsd) inhibitors |
| CN110698411B (zh) * | 2018-07-09 | 2023-05-09 | 四川大学 | 一类4-(胺烷基)酞嗪-1-酮类化合物、其制备方法和用途 |
| EP4188383A4 (en) * | 2020-07-28 | 2025-01-08 | Mirati Therapeutics, Inc. | SOS1 INHIBITORS |
| WO2022187804A1 (en) * | 2021-03-02 | 2022-09-09 | Icahn School Of Medicine At Mount Sinai | Benzoxazolone inhibitors of inflammasomes |
| WO2024192873A1 (zh) * | 2023-03-20 | 2024-09-26 | 杭州天玑济世生物科技有限公司 | 一类具有萘胺结构的小分子化合物的用途 |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA775563A (en) | 1968-01-09 | Frank W. Horner Limited | Hypoglycemic thiadiazoles | |
| GB828963A (en) | 1956-08-03 | 1960-02-24 | Rhone Poulenc Sa | Pharmaceutical compositions containing 2-p-aminobenzenesulphonamido-5-t-butyl-1, 3, 4-thiadiazole |
| US3821222A (en) | 1971-11-22 | 1974-06-28 | Chevron Res | Hydrocarbyl sulfenylmercapto pyrimidines |
| US4017489A (en) | 1975-07-10 | 1977-04-12 | The Goodyear Tire & Rubber Company | Process of preparing unsymmetrical disulfides |
| DE2556011A1 (de) | 1975-12-12 | 1977-06-23 | Merck Patent Gmbh | Disulfide |
| IE47592B1 (en) * | 1977-12-29 | 1984-05-02 | Ici Ltd | Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture |
| GB2152497B (en) | 1983-11-28 | 1987-08-05 | Otsuka Kagaku Kk | Process for the preparation of azetidinone derivatives |
| FR2573077B1 (fr) | 1984-11-13 | 1987-02-13 | Sanofi Sa | Nouveaux derives thiosulfonates, leur procede de preparation ainsi que les compositions pharmaceutiques les contenant |
| US4939140A (en) | 1985-11-07 | 1990-07-03 | Pfizer Inc. | Heterocyclic oxophthalazinyl acetic acids |
| US4990523A (en) | 1989-06-19 | 1991-02-05 | A. H. Robins Company, Incorporated | Treatment of chronic inflammatory joint disease with arylsulfonamides |
| GB9507415D0 (en) * | 1994-06-08 | 1995-05-31 | Zylepsis Ltd | Production and uses of caffeic acid and derivatives thereof |
| US6139875A (en) | 1998-09-29 | 2000-10-31 | Eastman Chemical Company | Aqueous enteric coating composition and low gastric permeability enteric coating |
| FR2815032B1 (fr) | 2000-10-10 | 2003-08-08 | Pf Medicament | Nouveaux derives d'aminophenyle piperazine ou d'amino phenyle piperide inhibiteurs de proteines prenyl transferase ainsi que leurs preparations |
| EP1379250A2 (en) | 2001-04-10 | 2004-01-14 | Merck & Co., Inc. | A method of treating cancer |
| CN1568187A (zh) * | 2001-08-15 | 2005-01-19 | Icos股份有限公司 | 2h－2,3－二氮杂萘－1－酮和其使用方法 |
| GB0205693D0 (en) | 2002-03-09 | 2002-04-24 | Astrazeneca Ab | Chemical compounds |
| EP1496981A2 (en) | 2002-04-08 | 2005-01-19 | Merck & Co., Inc. | Method of treating cancer |
| GB0215823D0 (en) * | 2002-07-09 | 2002-08-14 | Astrazeneca Ab | Quinazoline derivatives |
| US20040102360A1 (en) | 2002-10-30 | 2004-05-27 | Barnett Stanley F. | Combination therapy |
| AU2004251105B2 (en) | 2003-06-24 | 2010-04-01 | Isis Innovation Limited | Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins |
| CA2531418A1 (en) | 2003-07-08 | 2005-01-20 | Novartis Ag | Benzenesulfonylamino compounds and pharmaceutical compositions containing these compounds |
| WO2005090461A2 (en) | 2004-03-19 | 2005-09-29 | The Tapemark Company | Thermoplastic films and methods for making |
| US20050288347A1 (en) | 2004-03-26 | 2005-12-29 | Hodge Carl N | Certain triazole-based compounds, compositions, and uses thereof |
| SE0402635D0 (sv) | 2004-10-29 | 2004-10-29 | Astrazeneca Ab | Chemical compounds |
| DE102005011822A1 (de) * | 2005-03-15 | 2006-09-21 | Merck Patent Gmbh | Phthalazinone |
| AU2006299087A1 (en) | 2005-10-06 | 2007-04-12 | Sanofi-Aventis | Cyclic N-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
| WO2007106391A1 (en) | 2006-03-10 | 2007-09-20 | Lymphosign Inc. | Compounds for modulating cell proliferation, compositions and methods related thereto |
| GB2453058A (en) | 2006-04-04 | 2009-03-25 | Univ California | Kinase antagonists |
| EP2104489A2 (en) | 2006-12-26 | 2009-09-30 | FemmePharma Holding Company, Inc. | Topical administration of danazol |
| EP2291349A2 (en) | 2008-04-14 | 2011-03-09 | The Board of Regents of The University of Texas System | Small molecule inhibitors of the pleckstrin homology domain and methods for using same |
| WO2010085968A1 (en) * | 2008-12-30 | 2010-08-05 | European Molecular Biology Laboratory (Embl) | Toluidine sulfonamides and their use as hif-inhibitors |
| CN102448951B (zh) * | 2009-04-06 | 2017-05-10 | 安吉奥斯医药品有限公司 | 丙酮酸激酶m2调节剂、治疗组合物和相关使用方法 |
| CA2773561A1 (en) | 2009-09-14 | 2011-03-17 | Phusis Therapeutics Inc. | Pharmaceutical compositions and formulations including inhibitors of the pleckstrin homology domain and methods for using same |
| MX2013011450A (es) * | 2011-04-05 | 2014-02-03 | Vertex Pharma | Compuestos de aminopirazina utiles como inhibidores de la cinasa ataxia telangiectasia mutada y rad3 relacionados (atr). |
| CA2895162C (en) | 2012-12-14 | 2021-03-09 | D. Lynn Kirkpatrick | Methods and compositions for inhibiting cnksr1 |
-
2013
- 2013-12-16 CA CA2895162A patent/CA2895162C/en active Active
- 2013-12-16 MX MX2015007608A patent/MX372739B/es active IP Right Grant
- 2013-12-16 MX MX2019015648A patent/MX393754B/es unknown
- 2013-12-16 AU AU2013358876A patent/AU2013358876B2/en active Active
- 2013-12-16 JP JP2015548050A patent/JP6357292B2/ja active Active
- 2013-12-16 WO PCT/US2013/075505 patent/WO2014093988A2/en not_active Ceased
- 2013-12-16 US US14/649,349 patent/US9340532B2/en active Active
- 2013-12-16 EP EP13863280.7A patent/EP2931280B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2016508969A (ja) | 2016-03-24 |
| AU2013358876B2 (en) | 2018-05-10 |
| WO2014093988A2 (en) | 2014-06-19 |
| US20150307482A1 (en) | 2015-10-29 |
| CA2895162C (en) | 2021-03-09 |
| EP2931280A2 (en) | 2015-10-21 |
| MX2015007608A (es) | 2016-04-13 |
| EP2931280A4 (en) | 2016-06-01 |
| WO2014093988A3 (en) | 2014-08-07 |
| US9340532B2 (en) | 2016-05-17 |
| MX393754B (es) | 2025-03-24 |
| AU2013358876A1 (en) | 2014-06-19 |
| CA2895162A1 (en) | 2014-06-19 |
| EP2931280B1 (en) | 2018-02-14 |
| JP6357292B2 (ja) | 2018-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112013025006A2 (pt) | composições e métodos para inibição de expressão do gene tmprss6 | |
| CO2018005381A2 (es) | Inhibidores éster de acc y usos de los mismos | |
| UY33958A (es) | Inhibidores de la glucosilceramida sintasa | |
| CO7091177A2 (es) | Inhibidores de la beta-secretasa | |
| BR112013028281A2 (pt) | compostos e composições para inibição de nampt | |
| UY33930A (es) | Inhibidores novedosos de quinasas | |
| UY33925A (es) | Inhibidores tricíclicos de quinasas | |
| CO7020912A2 (es) | Inhibidores de bromodominios | |
| CL2018003282A1 (es) | Métodos y composiciones para el tratamiento de cánceres resistentes a los inhibidores de la vía no erk mapk | |
| CR20140024A (es) | Compuestos inhibidores de metaloenzimas | |
| CO7111289A2 (es) | Compuestos inhibidores de metaloenzimas | |
| CR20140106A (es) | Compuestos y composiciones como inhibidores de la quinasa c-kit | |
| HRP20181199T1 (hr) | Laktamski derivati, korisni kao inhibitori mutantnog idh1 | |
| PT2773748T (pt) | Neurónios dopaminérgicos (da) do mesencéfalo para enxerto | |
| LT2841428T (lt) | Dnr-pk inhibitoriai | |
| DK2920149T3 (da) | 3-aminocycloalkyl-forbindelser som ror-gamma-t-inhibitorer og anvendelser deraf | |
| HUE037312T2 (hu) | Hiszton demetiláz inhibitorok | |
| BR112015023310A2 (pt) | composições, métodos e kits para redução de níveis lipídicos | |
| UY34027A (es) | Inhibidores sustituidos de acetil-coa carboxilasa. | |
| UY33929A (es) | Compuestos de ciclohexilo tetrasustituido como inhibidores de quinasas | |
| EA201500801A1 (ru) | Бензохинолоновые ингибиторы vmat2 | |
| BR112015003294A2 (pt) | caldeira de armazenamento | |
| CR20150133A (es) | Amino-quinolinas como inhibidores de cinasa | |
| MX372739B (es) | Metodos y composiciones para inhibir cnksr1. | |
| UY34800A (es) | Combinaciones farmacéuticas que contienen un inhibidor de 11-beta-hidroxiesteroide dehidrogenasa-1 útil en trastornos metabólicos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |